Fig. 1

Correlation between decreased plasma FFA concentration and a increased PPAR-γ (n = 14; r =0.634, P = 0.015) or b G0S2 (n = 14; r = 0.613, P = 0.020) mRNA expression in PBMC in obese patients from the ALA-treated group
Correlation between decreased plasma FFA concentration and a increased PPAR-γ (n = 14; r =0.634, P = 0.015) or b G0S2 (n = 14; r = 0.613, P = 0.020) mRNA expression in PBMC in obese patients from the ALA-treated group